<?xml version="1.0" encoding="iso-8859-1"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>HHS/OIG-Audit--&quot;Review of Management Controls Over the Medicaid Prescription Drug Rebate Program, (A-06-92-00029)&quot;</title>
<meta name="Keywords" content="A-06-92-00029,
AUDIT,
HHS Office of Inspector General, OAS,
ISSUED: 06/1993,
Drugs,
Medicaid,
Centers for Medicare and Medicaid Services (CMS)" />
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1" />
</head>



<body>

<!-- Google Tag Manager -->
<noscript><iframe src="//www.googletagmanager.com/ns.html?id=GTM-JLFR"
height="0" width="0" style="display:none;visibility:hidden" title="googletagmanager"></iframe></noscript>
<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({"gtm.start":new Date().getTime(),event:"gtm.js"});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!="dataLayer"?"&l="+l:"";j.async=true;j.src="//www.googletagmanager.com/gtm.js?id="+i+dl;f.parentNode.insertBefore(j,f);})(window,document,"script","dataLayer","GTM-JLFR");</script>
<!-- End Google Tag Manager -->

<a href="#content"><img src="/images/skip_pixel.gif" alt="Skip to Content" style="border:0 !important" /></a>
<h2><a name="content"></a><em><!-- #BeginLibraryItem "/Library/top anchor.lbi" --><a name="top" id="top"></a><!-- #EndLibraryItem -->Department
    of Health and Human Services</em></h2>
<h3>Office of Inspector General -- AUDIT </h3>
<h3>&quot;Review of Management Controls Over the Medicaid Prescription Drug Rebate
  Program,&quot; (A-06-92-00029) </h3>
<h3>June 9, 1993</h3>
<hr noshade="noshade" />
<h5><a href="69200029.pdf">Complete
    Text of Report </a>is available in PDF format (1.54 MB). Copies can also be obtained
    by contacting the Office of Public Affairs at 202-619-1343.</h5>
<hr noshade="noshade" />
<strong>
<p>EXECUTIVE SUMMARY:</p>
</strong>
<p>This final report points out that the Health Care Financing Administration (HCFA)
  has not ensured that States have established adequate accountability and controls
  over the Medicaid drug rebate program. At the eight States we reviewed, we noted
  that (1) proper accountability had not been established over billing and collection
  of rebates, (2) six of the States did not have policies and procedures for settling
  disputes within the required time frame, (3) conflicting HCFA guidelines caused
  confusion regarding what a State is required to bill drug manufacturers, and (4)
  internal controls had not been established over rebate program funds. The HCFA
  concurred with our recommendations for corrective action. </p>
<!-- #BeginLibraryItem "/Library/bottom.lbi" -->

<!-- #EndLibraryItem --></body>
</html>
